BioXcel (BTAI) Stock Climbs As FDA Clears Clinical Trial Site Inspection
Fahim Awan
March 3, 2025
Following a significant regulatory update, BioXcel Therapeutics, Inc. (NASDAQ: BTAI) stock saw a sharp increase in value. As of the recent market check, BTAI stock